Fukoku Mutual Life Insurance CO Novavax Inc Transaction History

Fukoku Mutual Life Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$36.28 - $75.29 $14,512 - $30,116	-400 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$69.73 - $142.9 $6,973 - $14,290	100 Added 33.33%	400 $29,000
Q4 2021 Jan 25, 2022	BUY	$134.56 - $217.97 $2,691 - $4,359	20 Added 7.14%	300 $43,000
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $14,224 - $21,646	80 Added 40.0%	280 $58,000
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $24,200 - $51,534	200 New	200 $42,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.